A liver tissueoid-on-a-chip with functional blood vessels, diverse liver cells, and immune activity replicates transplant ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a vascularized liver tissueoid-on-a-chip (LToC) platform that recapitulates key structural, functional, and immunological features of ...

As treatment options for acute myeloid leukemia (AML) evolve, new therapies could change the patient experience around allogeneic stem cell transplant. CURE sat down with Dr. Gwen Nichols, chief ...

Transplanting myoblasts in a fluid containing ECM helped new cells graft into existing tissue. To confirm engraftment, new cells have been designed to emit a green dye, as seen in the bottom right.

Credit: Getty Images. The goal of HCT is to cure an underlying malignancy or hematologic disorder. The procedure can be performed in an inpatient or outpatient setting. Each setting is associated with ...

Stem cell transplants remain essential for blood cancers, with expanded donor options including half-matched family members and umbilical cord blood. Cyclophosphamide has improved graft-versus-host ...

Transplanting hematopoietic stem cells from healthy individuals is one of the possible treatments for blood cancers. In Switzerland, it involves nearly 300 patients per year. However, nearly half of ...

Phase I clinical trial results suggest that an antibody treatment, used in combination with other drugs, enabled stem cell transplants for three children with Fanconi anemia without toxic busulfan ...

A recent study suggests that a freely available AI tool could help predict dangerous complications after stem cell transplants.